• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Tabebuia avellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivodermal irritability

Snowy Owl

Retired in 2010, In Memoriam
Annals of Clinical Microbiology and Antimicrobials
http://www.ann-clinmicrob.com

Research
Tabebuia avellanedaenaphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivodermal irritability analysis
Eliezer M Pereira, Thelma B Machado, Ivana CR Leal, Desiree M Jesus, Clarissa RA Damaso, Antonio V Pinto, Marcia Giambiagi-deMarval, Ricardo M Kuster, Katia RN Santos
Annals of Clinical Microbiology and Antimicrobials 2006, 5:5 (22 March 2006)
[Abstract] [Provisional PDF]


Research
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
David Styers, Daniel J Sheehan, Patricia Hogan, Daniel F Sahm
Annals of Clinical Microbiology and Antimicrobials 2006, 5:2 (9 February 2006)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

Ventilator associated pneumonia and infection control
Emine E Alp and Andreas A Voss

Annals of Clinical Microbiology and Antimicrobials 2006, 5:7 doi:10.1186/1476-0711-5-7

Published 6 April 2006

Abstract (provisional)

Ventilator associated pneumonia (VAP) is the leading cause of morbidity and mortality in intensive care units. The incidence of VAP varies from 7% to 70% in different studies and the mortality rates are 20-75% according to the study population. Aspiration of colonized pathogenic microorganisms on the oropharynx and gastrointestinal tract is the main route for the development of VAP. On the other hand, the major risk factor for VAP is intubation and the duration of mechanical ventilation. Diagnosis remains difficult, and studies showed the importance of early initiation of appropriate antibiotic for prognosis. VAP causes extra length of stay in hospital and intensive care units and increases hospital cost. Consequently, infection control policies are more rational and will save money.

PDF
http://www.ann-clinmicrob.com/content/pdf/1476-0711-5-7.pdf

http://www.ann-clinmicrob.com/content/5/1/7
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

Is VAP the same as ARDS? Or is an ARDS a result of the intubation without proper treatment of the underlying pathogen(s)?

If H5N1 goes H2H, there may be lots of people on ventilators due to cytokine storm and resulting ARDS.....

It seems that lots of research is going into H5N1... how much research is happening to reduce the cytokine storm and ARDS?

Sorry for all the questions.... I learn by asking questions.
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

No Lob.

Vap is Ventilator Associated Pneumonia, while
ARDS is Acute Respiratory Distress Syndrome.
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

ARDS can happen without intubation or Ventilation.
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

I have learned "a little bit about ARDS" in my life. My father had three lobes of his lungs removed due to cancer and was on a ventilator for a short period during surgery. He developed ARDS and survived for three years. He is mentioned in "journals" as a case worth mentioning due to his atypical recovery. (No B.S. here). He lived for three years with only two lobes of his lung after recovering from ARDS.

I have also been actively studying the works of Dr. James Reason. ARDS is an area that his work has been actively applied to.

I want to know the similarities and the differences between VAP and ARDS (if there are any). Don't give me the short answer, I have already heard it and am well beyond that knowledge level. It looks like a duck and quacks like a duck to me.
 
Re: Annals of Clinical Microbiology and Antimicrobials

Re: Annals of Clinical Microbiology and Antimicrobials

Lob,

I am not a specialist, I have only stated what I recall in my lecture of litterature.

You seems more knowledgeable than I on this matter, I feel that you do have a lot to say about this.

Please allow yourself, I am always eager to learn, specifically on ARDS and VAP. since we might have to deal with these more often than willing to.
 
Back
Top